Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2024 | Enhancing clinical trial participation through community engagement

Inimfon Jackson • 13 Dec 2024
SABCS 2024
Breast Cancer

Inimfon Jackson, MD, PhD, MPH, The University of Texas MD Anderson Cancer Center, Houston, TX, explores strategies to improve clinical trial participation among underserved communities. Approaches include building trust through community engagement and integrating patient navigation into clinical care. Patient navigators, who guide and support patients in their preferred language, address fears and logistical challenges. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Inimfon Jackson

Addressing access barriers and guideline-concordant breast cancer care
1:07
Addressing access barriers and guideline-concordant breast cancer care
Inimfon Jackson • 10 Dec 2025
Real-world use, disparities and outcomes of neoadjuvant chemo-IO in TNBC
2:28
Real-world use, disparities and outcomes of neoadjuvant chemo-IO in TNBC
Inimfon Jackson • 10 Dec 2025
Chemotherapy declination among patients with early-stage breast cancer and high Oncotype DX scores
1:53
Chemotherapy declination among patients with early-stage breast cancer and high Oncotype DX scores
Inimfon Jackson • 30 May 2025
Navigating discussions with patients who have high-risk genomics but are reluctant about chemo
0:57
Navigating discussions with patients who have high-risk genomics but are reluctant about chemo
Inimfon Jackson • 30 May 2025

Related Videos

Radiation response as a biomarker for adjuvant breast cancer therapy
1:56
Radiation response as a biomarker for adjuvant breast cancer therapy
Corey Speers • 1 Jun 2026
Expanding the clinical use of multimodal AI in breast cancer care
1:38
Expanding the clinical use of multimodal AI in breast cancer care
Corey Speers • 1 Jun 2026
MMAI model validation for chemotherapy benefit prediction in breast cancer
1:58
MMAI model validation for chemotherapy benefit prediction in breast cancer
Corey Speers • 1 Jun 2026
GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: a real-world analysis
1:33
GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: a real-world analysis
Zunairah Shah • 30 May 2026
The content of VJOncology is intended for healthcare professionals